Jin‐Ji Yang

Guangdong Academy of Medical Sciences — China

Medicine · Health Sciences

50h-index8.8kcitations293works6.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(225), Lung Cancer Research Studies(84), Cancer Genomics and Diagnostics(57), Cancer Immunotherapy and Biomarkers(52), Lung Cancer Diagnosis and Treatment(45)

Publications291 total

Clinical Progression Modes of Crizotinib Failure and Subsequent Management of Advanced Non‐Small Cell Lung Cancer With <i>ROS</i> 1 Rearrangement
Cancer Medicine·2026Open Access
Longitudinal <i>in vivo</i> ( <i>R</i> )-[ <sup>18</sup> F]FBFP PET imaging for preclinical evaluation of cerebral sigma-1 receptor after ischemic stroke
Theranostics·2025Open Access
The effect of structural variation of the long arm of rye 6R on its meiotic behavior and the location of a segment with powdery mildew resistance
The Crop Journal·2025Open Access
LBA52 Nofazinlimab combined with lenvatinib versus placebo plus lenvatinib as first-line therapy for unresectable or metastatic hepatocellular carcinoma: A phase III, randomized, double-blind, multiregional study (CS1003-305)
Annals of Oncology·2025Open Access
1316eTiP A phase Ib trial of CS5001 (ROR1-ADC) as a single agent and in combination with systemic therapies in patients with advanced solid tumours and lymphomas
Annals of Oncology·2025
Clinical outcomes and neuroendocrine features of transformed versus primary small-cell lung cancer
Lung Cancer·2025
Screening for Primary Aldosteronism is Underutilised in Patients With Atrial Fibrillation: A Retrospective Cohort Study
Heart Lung and Circulation·2025Open Access
Global, regional, and national burden of multiple myeloma, 1990 to 2021 and predictions to 2035: an analysis of the Global Burden of Disease Study 2021
Frontiers in Medicine·2025· 1 citedOpen Access
Exploring YAP1-related TIME in SCLC: implications for survival and treatment response to immuno-chemotherapy
Cancer Drug Resistance·2025Open Access
A Mutually Reinforcing Semi-supervised Active Learning Framework for Lung Surgical Section Image Classification
Lecture notes in computer science·2025
<scp>APOC1</scp> inhibit <scp>NKTCL</scp> doxorubicin sensitivity by promoting mitophagy
IUBMB Life·2025
LungNeXt: An Attention-Based Classification Network for Non-standard Medical Images of Lung Tumors
Communications in computer and information science·2025
Capillary reinforcement strategy guided construction of robust oxygen functionalized carbon-based porous foam for highly efficient solar evaporation
Separation and Purification Technology·2024
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC
Cell Reports·2024· 19 citedOpen Access
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
The Lancet Oncology·2024· 72 citedOpen Access
Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study
The Lancet Respiratory Medicine·2024· 7 cited
Combination of Cytologic Findings and Circulating Tumor DNA From Cerebrospinal Fluid Revealed SCLC Transformation in Patients With Leptomeningeal Metastases of Lung Adenocarcinoma
JTO Clinical and Research Reports·2024Open Access
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non−Small Cell Lung Cancer
JAMA Oncology·2024· 54 citedOpen Access
Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION
British Journal of Cancer·2024· 4 citedOpen Access
Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer
Journal of Translational Medicine·2024· 10 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

Yi‐Long Wu(50), Qing Zhou(35), Wen‐Zhao Zhong(33), Xu‐Chao Zhang(30), Hong‐Hong Yan(28), Jian Su(24), Hai‐Yan Tu(23), Xue‐Ning Yang(22), Chong‐Rui Xu(13), Zhihong Chen(12), Zhi Xie(11), Si‐Yang Maggie Liu(11), Hua‐Jun Chen(11), Ben‐Yuan Jiang(10), Zhong‐Yi Dong(8), Ying Cheng(8), Zhen Wang(8), Ri-Qiang Liao(7), Bin-Chao Wang(7), Cheng Huang(6)